Actemium Belgium
Léon Bekaertlaan 24
9880 Aalter
BE
Actemium Belgium
Foundation date
28/05/1985
Sector
#Supplier & EngineeringSubsector
- #Professional Services - IT services
- #Supplier - Instrumentation
- #Supplier - Laboratory engineering
- #Supplier - Packaging & labeling
- #Supplier - Production engineering
- #Supplier - Software/eHealth
Therapeutic areas
- #Diseases of the blood and blood-forming organs - immune disorders
- #Musculoskeletal system and connective tissue
- #Respiratory system
- #Skin and subcutaneous tissue
Actemium Belgium has developed an established reputation in advice, study, realization and support for industrial processes as well as machine & logistic solutions by providing a comprehensive offer in electricity, instrumentation, automation and assembly, including a whole range of service possibilities and complete training programs. Actemium is active in a wide range of sectors including the Life Science industry.
The world is changing – especially around the Life Sciences ecosystem. This is a market that’s growing sustainably, and placing innovation and quality, front and center. That way it can effectively produce safe, targeted therapies for patients, at the same time as keeping prices affordable and meeting strict regulatory requirements.
You need reliable partners to support you when tackling tomorrow’s challenges. And that applies whether these involve digital transformation, cybersecurity, switching to a patient-centric approach, operational efficiency, process solutions or environmental sustainability. Actemium’s long-standing expertise and worldwide network of 350 business units 100% dedicated to industry will help you face them down, find new opportunities and add more value.
Upcoming events
All events-
1012 '24
Next-Generation Synthetic Biology
Event by: VIB -
0312 '24
BioFIT 2024
Event by: Eurasanté -
0204 '25
The Franco-Belgian Agrifood Summit
Event by: CCI France - Belgique
Latest news
More news-
Bio Base Europe Pilot Plant successfully commissions a 75,000 L fermenter, demonstrating Vivici’s Vivitein™ BLG technology in industrial-scale precision fermentation
9 hours ago
Read more
-
argenx Advances Clinical Development of Efgartigimod SC in Idiopathic Inflammatory Myopathies
1 day ago
Read more
-
ExeVir Announces Michael Garrett as New Chief Executive Officer
Tuesday November 19th 2024
Read more
Jobs
More jobs-
-
-
20/11/24
Antwerp
Postdoc position in the Laboratory for Gut-Immune-Brain Axis Research
Permanent
VIB
More info?
Ellen Telleir
Communication Coordinator